Neurotechnology startup Sychedelic has successfully raised $3.5 million in its seed funding round from a consortium of investors. The investment was supported by firms including Cultadvisors LLP, TurboStart, Ideabaaz, and Praveek Ventures, alongside several angel investors. This capital infusion will fuel the company's mission to advance mental wellness through its innovative wearable technology designed for everyday use.
Strategic Allocation of New Capital
The company plans to strategically allocate the fresh capital toward several key areas of growth. These funds will be instrumental in scaling manufacturing operations, expanding research and development capabilities, and amplifying marketing initiatives. This financial backing also provides crucial support for the startup's planned global Kickstarter launch, which is slated for June 2026.
Innovative Neurotechnology for Wellness
At the heart of Sychedelic's innovation is a pair of headphones designed as a "closed-loop neuromodulation wearable" for daily use. The device integrates photoplethysmography (PPG) sensors, adaptive audio, and transcranial direct current stimulation (tDCS) technology. This combination allows the system to monitor a user's stress and cognitive state in real time and deliver personalized interventions.
From Neurofeedback to Neuromodulation
Founded in 2020 by the husband-wife duo Ria Rustagi and Bhavya Madan, the company initially operated under the name Neuphony. In its early phase, the startup focused on developing EEG-based neurofeedback headbands designed to track brain activity and mental wellness indicators. The team later pivoted to the Sychedelic brand to develop its advanced neuromodulation headphones for a broader consumer market.
Validation and Regulatory Milestones
The product has undergone significant real-world testing, with more than 100 early users providing feedback over the last six months. This user input has been vital for refining the device's hardware, adaptive algorithms, and overall stimulation technology. As a major regulatory achievement, the startup has also secured approval from India's Central Drugs Standard Control Organisation (CDSCO).
Sychedelic has further solidified its position by filing global patent applications for its proprietary technology. The company claims its system is among the first to adapt neurostimulation in real time based on live biometric feedback. To support its international ambitions, the startup currently operates across India and the United States with a Delaware-based entity.
Navigating a Growing Market
This funding arrives as the wearable healthtech market evolves beyond basic fitness tracking toward more specialized applications. A new wave of startups is focusing on neurotechnology and biofeedback products aimed at stress reduction, focus enhancement, and sleep optimization. Sychedelic enters a competitive field that includes emerging companies such as Sputnik Brain, Mave Health, and Dusq.
The growing investor interest in this sector is further evidenced by recent funding for competitors like Mave Health and Temple. This trend aligns with projections for the Indian smart wearables market, which is estimated to reach a value of $10.26 billion by 2031. The market's expansion reflects a rising consumer demand for sophisticated health and wellness monitoring devices.
With this new injection of capital, Sychedelic is well-positioned to accelerate its growth and prepare for its international debut. The company's focus on combining biometric sensing with adaptive neurostimulation aims to make proactive mental wellness more accessible and personalized. As it moves toward its global launch, Sychedelic is poised to become a significant player in the rapidly expanding consumer neurotechnology space.